| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |